Actively Recruiting
A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
Led by Boryung Pharmaceutical Co., Ltd · Updated on 2025-09-15
120
Participants Needed
2
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia
CONDITIONS
Official Title
A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of schizophrenia according to DSM-5 criteria where a low or standard olanzapine dose is considered appropriate by the investigator
- Schizophrenia duration of more than 1 year at screening visit
You will not qualify if you...
- Diagnosis of schizophrenia spectrum and other psychotic disorders (e.g., schizoaffective disorder), bipolar disorder, or depressive disorder at screening visit
- Hospitalization for worsening schizophrenia within 12 weeks prior to screening visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kyungbook National university hospital
Daegu, South Korea
Actively Recruiting
2
Hanyang University Guri Hospital
Guri-si, South Korea
Not Yet Recruiting
Research Team
S
Shin-young Oh
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here